McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
749.76
-5.99 (-0.79%)
Oct 9, 2025, 11:28 AM EDT - Market open
McKesson Revenue
McKesson had revenue of $97.83B in the quarter ending June 30, 2025, with 23.39% growth. This brings the company's revenue in the last twelve months to $377.60B, up 20.35% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$377.60B
Revenue Growth
+20.35%
P/S Ratio
0.25
Revenue / Employee
$7,403,824
Employees
51,000
Market Cap
93.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
MCK News
- 8 days ago - See How McKesson Shares Rise with Money Flows - FXEmpire
- 15 days ago - McKesson Corporation (MCK) Analyst/Investor Day Transcript - Seeking Alpha
- 16 days ago - McKesson lifts annual profit forecast on plans to focus on high-margin businesses - Reuters
- 16 days ago - McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day - Business Wire
- 21 days ago - Drug distributor McKesson to restructure segments to focus on high-margin businesses - Reuters
- 21 days ago - McKesson Announces New Organizational Structure - Business Wire
- 2 months ago - McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mckesson lifts annual profit forecast on robust demand for specialty drugs - Reuters